San Francisco, CA (1888PressRelease)
May 20, 2008 - Kane & Finkel Healthcare Communications has been named one of the San Francisco Business Times’ “Best Places To Work in the Bay Area,” in the Small Business Category (51-100 employees).
The award is based on topics such as workplace culture, trust, employee satisfaction, benefits, management styles, and more. It is based on anonymous employee surveys.
“After 11 years in an industry famous for top-down management, corporate roll-ups, and high employee turn-over, we’ve always known that we were a little different” says Bob Finkel, Principal and Chief Creative Officer.
Creative Director Jonathan Peischl adds “The agency partners are not only alive, but in the building and working on the day-to-day creative and strategic challenges. The front of the shop enjoys and respects the back, and vice versa. While our office represents a wide spectrum of personalities, interests, and talents, we care about each other like family.” Peischl continues, “We are thrilled that our eclectic, energetic, intelligent, and noisy group has received an award of this nature, and look forward to another year of helping our clients while having a blast doing so.”
About Kane & Finkel
Kane & Finkel is a full-service healthcare communications agency headquartered in San Francisco, with a second office in Boston. Now in its 11th year in business, the agency provides comprehensive marketing, global branding, and promotional and educational communications services focused on the pharmaceutical, biotechnology, medical device, diagnostic, and consumer health sectors.
Kane & Finkel is ranked among the top 20 US healthcare marketing and communications agencies by Med Ad News, making it the number-one independently owned and operated agency on the West Coast. The company’s diverse client roster includes Accera, Inc.;Astellas Pharma Europe Ltd.; Astellas Pharma US, Inc.; CollaGenex Pharmaceuticals, Inc.; Dendreon Corporation; FzioMed, Inc.; Gilead Sciences, Inc.; OrthoNeutrogena; PDL BioPharma, Inc.; Questcor Pharmaceuticals, Inc.; Roche Molecular Diagnostics; Santen Incorporated; and UCB Pharma, Inc. For more information about Kane & Finkel Healthcare Communications, visit www.kaneandfinkel.com or e-mail press ( @ ) kaneandfinkel dot com.
###
